BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 21815139)

  • 1. High prevalence and breast cancer predisposing role of the BLM c.1642 C>T (Q548X) mutation in Russia.
    Sokolenko AP; Iyevleva AG; Preobrazhenskaya EV; Mitiushkina NV; Abysheva SN; Suspitsin EN; Kuligina ESh; Gorodnova TV; Pfeifer W; Togo AV; Turkevich EA; Ivantsov AO; Voskresenskiy DV; Dolmatov GD; Bit-Sava EM; Matsko DE; Semiglazov VF; Fichtner I; Larionov AA; Kuznetsov SG; Antoniou AC; Imyanitov EN
    Int J Cancer; 2012 Jun; 130(12):2867-73. PubMed ID: 21815139
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A common nonsense mutation of the BLM gene and prostate cancer risk and survival.
    Antczak A; Kluźniak W; Wokołorczyk D; Kashyap A; Jakubowska A; Gronwald J; Huzarski T; Byrski T; Dębniak T; Masojć B; Górski B; Gromowski T; Nagorna A; Gołąb A; Sikorski A; Słojewski M; Gliniewicz B; Borkowski T; Borkowski A; Przybyła J; Sosnowski M; Małkiewicz B; Zdrojowy R; Sikorska-Radek P; Matych J; Wilkosz J; Różański W; Kiś J; Bar K; Domagała P; Stawicka M; Milecki P; Akbari MR; Narod SA; Lubiński J; Cybulski C; ; ; Bryniarski P; Paradysz A; Jersak K; Niemirowicz J; Słupski P; Jarzemski P; Skrzypczyk M; Dobruch J; Domagała W; Chosia M; van de Wetering T; Serrano-Fernández P; Puszyński M; Soczawa M; Switała J; Archimowicz S; Kordowski M; Zyczkowski M; Borówka A; Bagińska J; Krajka K; Szwiec M; Haus O; Janiszewska H; Stembalska A; Sąsiadek MM
    Gene; 2013 Dec; 532(2):173-6. PubMed ID: 24096176
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Double heterozygotes among breast cancer patients analyzed for BRCA1, CHEK2, ATM, NBN/NBS1, and BLM germ-line mutations.
    Sokolenko AP; Bogdanova N; Kluzniak W; Preobrazhenskaya EV; Kuligina ES; Iyevleva AG; Aleksakhina SN; Mitiushkina NV; Gorodnova TV; Bessonov AA; Togo AV; Lubiński J; Cybulski C; Jakubowska A; Dörk T; Imyanitov EN
    Breast Cancer Res Treat; 2014 Jun; 145(2):553-62. PubMed ID: 24800916
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of breast tumors in CHEK2, NBN/NBS1 and BLM mutation carriers does not commonly involve somatic inactivation of the wild-type allele.
    Suspitsin EN; Yanus GA; Sokolenko AP; Yatsuk OS; Zaitseva OA; Bessonov AA; Ivantsov AO; Heinstein VA; Klimashevskiy VF; Togo AV; Imyanitov EN
    Med Oncol; 2014 Feb; 31(2):828. PubMed ID: 24415413
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nonsense mutation p.Q548X in BLM, the gene mutated in Bloom's syndrome, is associated with breast cancer in Slavic populations.
    Prokofyeva D; Bogdanova N; Dubrowinskaja N; Bermisheva M; Takhirova Z; Antonenkova N; Turmanov N; Datsyuk I; Gantsev S; Christiansen H; Park-Simon TW; Hillemanns P; Khusnutdinova E; Dörk T
    Breast Cancer Res Treat; 2013 Jan; 137(2):533-9. PubMed ID: 23225144
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence of the BLM nonsense mutation, p.Q548X, in ovarian cancer patients from Central and Eastern Europe.
    Bogdanova N; Togo AV; Ratajska M; Kluźniak W; Takhirova Z; Tarp T; Prokofyeva D; Bermisheva M; Yanus GA; Gorodnova TV; Sokolenko AP; Kuźniacka A; Podolak A; Stukan M; Wokołorczyk D; Gronwald J; Vasilevska D; Rudaitis V; Runnebaum IB; Dürst M; Park-Simon TW; Hillemanns P; Antonenkova N; Khusnutdinova E; Limon J; Lubinski J; Cybulski C; Imyanitov E; Dörk T
    Fam Cancer; 2015 Mar; 14(1):145-9. PubMed ID: 25182961
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Frequency and molecular characteristics of PALB2-associated cancers in Russian patients.
    Preobrazhenskaya EV; Shleykina AU; Gorustovich OA; Martianov AS; Bizin IV; Anisimova EI; Sokolova TN; Chuinyshena SA; Kuligina ES; Togo AV; Belyaev AM; Ivantsov AO; Sokolenko AP; Imyanitov EN
    Int J Cancer; 2021 Jan; 148(1):203-210. PubMed ID: 32997802
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The frequency of the BLM*p.Q548X (c.1642C > T) mutation in breast cancer patients from Russia.
    Imyanitov E; Prokofyeva D; Bogdanova N; Dörk T
    Breast Cancer Res Treat; 2014 Dec; 148(3):695-6. PubMed ID: 25410042
    [No Abstract]   [Full Text] [Related]  

  • 9. The frequency of the BLM p.Q548X (c.1642C>T) mutation in breast cancer patients from Russia is no higher than in the general population.
    Anisimenko MS; Kozyakov AE; Paul GA; Kovalenko SP
    Breast Cancer Res Treat; 2014 Dec; 148(3):689-90. PubMed ID: 25399228
    [No Abstract]   [Full Text] [Related]  

  • 10. Germline BLM mutations and metastatic prostate cancer.
    Ledet EM; Antonarakis ES; Isaacs WB; Lotan TL; Pritchard C; Sartor AO
    Prostate; 2020 Feb; 80(2):235-237. PubMed ID: 31816118
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Deleterious Germline BLM Mutations and the Risk for Early-onset Colorectal Cancer.
    de Voer RM; Hahn MM; Mensenkamp AR; Hoischen A; Gilissen C; Henkes A; Spruijt L; van Zelst-Stams WA; Kets CM; Verwiel ET; Nagtegaal ID; Schackert HK; van Kessel AG; Hoogerbrugge N; Ligtenberg MJ; Kuiper RP
    Sci Rep; 2015 Sep; 5():14060. PubMed ID: 26358404
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Exome sequencing identifies rare deleterious mutations in DNA repair genes FANCC and BLM as potential breast cancer susceptibility alleles.
    Thompson ER; Doyle MA; Ryland GL; Rowley SM; Choong DY; Tothill RW; Thorne H; ; Barnes DR; Li J; Ellul J; Philip GK; Antill YC; James PA; Trainer AH; Mitchell G; Campbell IG
    PLoS Genet; 2012 Sep; 8(9):e1002894. PubMed ID: 23028338
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Candidate gene analysis of BRCA1/2 mutation-negative high-risk Russian breast cancer patients.
    Sokolenko AP; Preobrazhenskaya EV; Aleksakhina SN; Iyevleva AG; Mitiushkina NV; Zaitseva OA; Yatsuk OS; Tiurin VI; Strelkova TN; Togo AV; Imyanitov EN
    Cancer Lett; 2015 Apr; 359(2):259-61. PubMed ID: 25619955
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Heterozygous germline
    Bononi A; Goto K; Ak G; Yoshikawa Y; Emi M; Pastorino S; Carparelli L; Ferro A; Nasu M; Kim JH; Suarez JS; Xu R; Tanji M; Takinishi Y; Minaai M; Novelli F; Pagano I; Gaudino G; Pass HI; Groden J; Grzymski JJ; Metintas M; Akarsu M; Morrow B; Hassan R; Yang H; Carbone M
    Proc Natl Acad Sci U S A; 2020 Dec; 117(52):33466-33473. PubMed ID: 33318203
    [TBL] [Abstract][Full Text] [Related]  

  • 15. BLM germline and somatic PKMYT1 and AHCY mutations: Genetic variations beyond MYCN and prognosis in neuroblastoma.
    Novak EM; Halley NS; Gimenez TM; Rangel-Santos A; Azambuja AM; Brumatti M; Pereira PL; Vince CS; Giorgi RR; Bendit I; Cristofani LM; Odone-Filho V
    Med Hypotheses; 2016 Dec; 97():22-25. PubMed ID: 27876123
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Frequency and spectrum of founder and non-founder BRCA1 and BRCA2 mutations in a large series of Russian breast cancer and ovarian cancer patients.
    Sokolenko AP; Sokolova TN; Ni VI; Preobrazhenskaya EV; Iyevleva AG; Aleksakhina SN; Romanko AA; Bessonov AA; Gorodnova TV; Anisimova EI; Savonevich EL; Bizin IV; Stepanov IA; Krivorotko PV; Berlev IV; Belyaev AM; Togo AV; Imyanitov EN
    Breast Cancer Res Treat; 2020 Nov; 184(1):229-235. PubMed ID: 32776218
    [TBL] [Abstract][Full Text] [Related]  

  • 17. First Two Cases of Bloom Syndrome in Russia: Lack of Skin Manifestations in a
    Suspitsin EN; Sibgatullina FI; Lyazina LV; Imyanitov EN
    Mol Syndromol; 2017 Mar; 8(2):103-106. PubMed ID: 28611551
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transcriptomic and Protein Expression Analysis Reveals Clinicopathological Significance of Bloom Syndrome Helicase (BLM) in Breast Cancer.
    Arora A; Abdel-Fatah TM; Agarwal D; Doherty R; Moseley PM; Aleskandarany MA; Green AR; Ball G; Alshareeda AT; Rakha EA; Chan SY; Ellis IO; Madhusudan S
    Mol Cancer Ther; 2015 Apr; 14(4):1057-65. PubMed ID: 25673821
    [TBL] [Abstract][Full Text] [Related]  

  • 19. NBS1 657del5 mutation may contribute only to a limited fraction of breast cancer cases in Russia.
    Buslov KG; Iyevleva AG; Chekmariova EV; Suspitsin EN; Togo AV; Kuligina ESh; Sokolenko AP; Matsko DE; Turkevich EA; Lazareva YR; Chagunava OL; Bit-Sava EM; Semiglazov VF; Devilee P; Cornelisse C; Hanson KP; Imyanitov EN
    Int J Cancer; 2005 Apr; 114(4):585-9. PubMed ID: 15578693
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The risk for developing cancer in Israeli ATM, BLM, and FANCC heterozygous mutation carriers.
    Laitman Y; Boker-Keinan L; Berkenstadt M; Liphsitz I; Weissglas-Volkov D; Ries-Levavi L; Sarouk I; Pras E; Friedman E
    Cancer Genet; 2016 Mar; 209(3):70-4. PubMed ID: 26778106
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.